Iohexol was first listed in Norway and Sweden in 1982. It is a kind of second-generation non-ionic monomeric contrast agent. Iopromide, Iomeprol, etc. Iohexol has low osmotic pressure, low toxicity to the nervous system, low contrast density, and good tolerance. It can be used for angiography, subarachnoid angiography, coronary angiography, spinal cord and femoral joints, urology angiography, and enhanced CT scanning. Etc., is the "gold standard" for evaluating various X-ray contrast agents in the medical community.
According to our (Global Info Research) latest study, the global Iohexol API market size was valued at US$ 610 million in 2023 and is forecast to a readjusted size of USD 959 million by 2030 with a CAGR of 6.7% during review period.
Global key manufacturers of Iohexol API include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%. Europe is the largest market of Iohexol API, holds a share over 60%. In terms of product, the Original Drug holds a larger segment, with a share over 80%. And in terms of application, the largest application is Hospitals, with a share of over 90%.
This report is a detailed and comprehensive analysis for global Iohexol API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Iohexol API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
Global Iohexol API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
Global Iohexol API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030
Global Iohexol API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Iohexol API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Iohexol API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Otsuka Chemicals, Justesa Imagen, Starry Pharmaceutical, Haichang Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Iohexol API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Original Drug
Generic Drug
Market segment by Application
Hospitals
Clinics
Major players covered
GE Healthcare
Otsuka Chemicals
Justesa Imagen
Starry Pharmaceutical
Haichang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iohexol API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Iohexol API, with price, sales quantity, revenue, and global market share of Iohexol API from 2019 to 2024.
Chapter 3, the Iohexol API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iohexol API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Iohexol API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Iohexol API.
Chapter 14 and 15, to describe Iohexol API sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Iohexol API. Industry analysis & Market Report on Iohexol API is a syndicated market report, published as Global Iohexol API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Iohexol API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.